BractonDeal Intel
Get full access
AcquisitionOther

JOHNSON & JOHNSON acquired Abiomed Strengthens Johnson & Johnson

Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.

Deal tape row

JOHNSON & JOHNSON -> Abiomed Strengthens Johnson & Johnson · $380.00

The transaction broadens Johnson & Johnson MedTech’s (JJMT) position as a growing cardiovascular innovator, advancing the standard of care in one of healthcare’s largest unmet need disease states: heart failure and recovery.

Open source record (SEC) ↗